Course description: 

Orthotic management of early stroke – A one day course

Within our busy clinical schedules, orthotists are often requested to provide opinion on orthotic intervention for stroke patients at all stages of their recovery. A common comment is we wish we had seen them earlier. If our wish came true. What would we do and what is the ideal approach for orthotic treatment from day one?

For physiotherapists, there are a plethora of evidence based interventions with little guidance for best approach treating and managing stroke survivors with motor impairments

Our course offers a well thought out clinically reasoned approach based on physiotherapy interventions and NICE guidelines to create a care pathway that gives patients and therapists the best opportunity to reach optimal recovery and independence.

This course commences with formal presentations supporting the pathway and leads to practical demonstration with patients.

Learning Outcomes: 
Orthotic management of early stroke
Background and understanding of stroke pathology
What’s the evidence for interventions?
Current practice and variability
A proposed model to optimise motor learning.
Practical assessment and clinical test
Simulating interventions
Complimentary interventions
Case studies

Intended Participants:
​​☒​ Orthotists
​​☒​ Orthotic support workers
​​☒​ Other: Physiotherapists

We encourage practising Orthotists or Orthotic Support Workers, who must be working in the UK, to apply for reimbursement from OETT (The Orthotic Education and Training Trust).
Course fee funding for non-BAPO members would be at the BAPO member rate for practising Orthotists or Orthotic Support Workers, who must be working in the UK only.
Applications can be made via the online applications link on the OETT website: www.oett.org.uk
Requests for reimbursement must include evidence of reflective learning/CPD.

A chance for discussion around the treatment options for pectus carinatum and excavatum, including

• orthotic assessment
• Prescription
• fitting protocols

We will be available to answer any specific questions to support the development of new or existing chest wall clinics.

Details

By the end of the session, the audience will gain insight into how Blesma works in partnership with clinical services to support military veterans in achieving independent and fulfilling lives.

The webinar will focus on the science behind Incrediwear, explain the therapeutic benefits, present clinical evidence and clinical applications.

Discover how wearable infrared technology is transforming patient care in this engaging and informative webinar focused on Incrediwear, an evidence-driven solution designed to accelerate recovery, reduce pain, and optimise function. Ideal for orthotists, physiotherapists, and wider healthcare professionals, this session will explore how Incrediwear’s innovative fabric technology works at the cellular level to increase blood flow, support natural healing processes, and improve outcomes in both acute and chronic conditions.
Participants will gain insight into the underlying science of semiconductor-embedded fibres, how these stimulate infrared emission, and the resulting physiological benefits. The webinar will include practical guidance on clinical applications across musculoskeletal injury, post-operative rehabilitation, vascular issues, and oedema management, as well as considerations for integrating Incrediwear into existing treatment pathways.

Real-world case examples will illustrate patient response, compliance advantages, and opportunities to enhance everyday practice. Whether you are new to Incrediwear or looking to deepen your understanding, this session will provide clear, actionable knowledge to support better decision-making and improved patient outcomes.
Join us to explore the growing role of wearable infrared technology in modern rehabilitation and discover how Incrediwear can complement your clinica ltoolkit.

Chronic low back pain (CLBP) is a major public health concern that will continue to grow with the expected aging of the population.
This webinar will introduce the participants to Apos, a non-invasive foot-worn medical device for the management of chronic lower limb and lower back pain.

It will present the outcomes of a recently published randomised controlled trial (RCT) which investigated the outcomes of the home-based biomechanical intervention (Apos) compared to standard care in patients with chronic lower back pain. The study was conducted following 3 retrospective studies that suggested positive outcomes of the intervention on the proposed cohort.
This RCT investigated the clinical outcomes in 162 patients with Chronic Low Back Pain (CLBP). Participants were randomised in a 2:1 ratio and assessed over a52-week period using the Numeric Rating Scale (NRS) as the primary outcome, alongside secondary measures including the Oswestry Disability Index (ODI)and gait parameters.
The trial was approved by the Albert Einstein College of Medicine IRB committee (ClinicalTrials.gov Identifier: NCT03167671) and conducted in the United States.

Satisfaction with the aesthetic appearance of a prosthetic limb is an important factor associated with psychosocial adjustment following an amputation. This TeaTime talk will explore aesthetic design alternatives for upper and lower limb prostheses, drawing upon principles from product development to help us understand how specific product properties (design elements) can elicit different emotional responses from users.

We will also reflect upon recent work exploring the psychosocial impact of lower limb prosthetic design, ending the session with some reflection over factors that may influence an individual preferences.

Microprocessor knees (MPKs) have been available on the NHS for established prosthetic users since April, 2017. Observations at our centre in an established cohort saw patients decreasing risk of falls and improving energy expenditure, alongside other physical and psychological benefits. This raised the question of whether MPKs should be considered for new post-amputation patients who also meet the NHS inclusion criteria (Clinical Commissioning Policy, 2016).

 

My poster aims to review one service’s experience with prescribing MPK’s to patients as their first prosthetic prescription to determine what selection criteria might ensure successful MPK use at 12 months.